Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PP2A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PP2A is a gene implicated in neurodegeneration research. Key relationships include: activates, inhibits, associated with. Associated with Aging, Als, Alzheimer. Connected to 141 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | PP2A |
| Full Name | Protein Phosphatase 2 Scaffold Subunit A Alpha |
| Aliases | PPP2R1A |
| Chromosome | 19q13.41 |
| Protein Type | Protein |
| Subcellular Localization | , and biological function 2. In the healthy brain, PP2A continuously |
| Molecular Weight | 65 kDa |
| Pathways | Wnt, Notch pathway, mTOR, mtor, Wnt signaling |
| UniProt ID | P30153 |
| NCBI Gene ID | 5518 |
| Ensembl ID | ENSG00000114825 |
| OMIM | 605983 |
| GeneCards | PP2A |
| Human Protein Atlas | PP2A |
| Associated Diseases | Aging, Als, Alzheimer, Alzheimer's disease, disease, neurodegeneration |
| Known Drugs/Compounds | donepezil, Donepezil, DONEPEZIL, metformin, rapamycin, resveratrol |
| Interactions | AKT, AKT1, ALPHA-SYNUCLEIN, ALZHEIMER, ALZHEIMER'S DISEASE, AMBRA1 |
| KG Connections | 343 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
PP2A["PP2A"]
tau["tau"]
PP2A -->|"regulates"| tau
Alzheimer{"Alzheimer"}
PP2A -->|"activates"| Alzheimer
Als{"Als"}
PP2A -->|"activates"| Als
Cancer{"Cancer"}
PP2A -->|"inhibits"| Cancer
PP2A -->|"inhibits"| Als
Tumor{"Tumor"}
PP2A -->|"inhibits"| Tumor
Diabetes{"Diabetes"}
PP2A -->|"activates"| Diabetes
Ms{"Ms"}
PP2A -->|"inhibits"| Ms
STAR["STAR"]
PP2A -->|"associated with"| STAR
Neurogenesis(["Neurogenesis"])
PP2A -->|"associated with"| Neurogenesis
Notch(["Notch"])
PP2A -->|"associated with"| Notch
GAIN["GAIN"]
PP2A -->|"inhibits"| GAIN
oxidative_stress["oxidative stress"]
oxidative_stress -->|"inhibits"| PP2A
PTEN["PTEN"]
PTEN -->|"regulates"| PP2A
GSK3_["GSK3beta"]
GSK3_ -->|"inhibits"| PP2A
PTEN -->|"inhibits"| PP2A
GAIN -->|"inhibits"| PP2A
STAR -->|"associated with"| PP2A
ERK["ERK"]
ERK -->|"activates"| PP2A
RCAN1["RCAN1"]
RCAN1 -->|"associated with"| PP2A
TNF["TNF"]
TNF -->|"activates"| PP2A
PI3K["PI3K"]
PI3K -->|"associated with"| PP2A
AKT["AKT"]
AKT -->|"activates"| PP2A
GLUCONEOGENIC_GENES["GLUCONEOGENIC GENES"]
GLUCONEOGENIC_GENES -->|"activates"| PP2A
style PP2A fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| AKT | inhibits | protein | 0.90 |
| Tau Phosphorylation | downregulates | process | 0.85 |
| Alzheimer | therapeutic_target | disease | 0.75 |
| Tumor | activates | disease | 0.75 |
| Als | activates | disease | 0.75 |
| oxidative stress response | participates_in | pathway | 0.70 |
| AMPK | activates | gene | 0.70 |
| Autophagy | inhibits | pathway | 0.70 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.70 |
| ALZHEIMER | therapeutic_target | gene | 0.70 |
| tau | regulates | protein | 0.70 |
| KEAP1 | activates | gene | 0.70 |
| NRF2 | activates | gene | 0.70 |
| Parkinson | inhibits | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Cardiac | interacts_with | disease | 0.65 |
| Ms | contributes_to | disease | 0.65 |
| Alzheimer | protects_against | disease | 0.65 |
| Tauopathy | protects_against | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Ataxia | regulates | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Als | treats | disease | 0.65 |
| Neurodegeneration | treats | disease | 0.65 |
| Alzheimer | treats | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Tauopathy | inhibits | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Senescence | associated_with | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Colorectal Cancer | inhibits | disease | 0.65 |
| Akt | associated_with | pathway | 0.60 |
| UBIQUITIN | associated_with | gene | 0.60 |
| PPP2R2A | regulates | gene | 0.60 |
| ULK1 | activates | gene | 0.60 |
| neurodegeneration | protects_against | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| DONEPEZIL | activates | drug | 0.80 |
| oxidative stress | inhibits | phenotype | 0.80 |
| Donepezil | activates | drug | 0.75 |
| GSK3β | inhibits | protein | 0.70 |
| PTEN | inhibits | protein | 0.70 |
| TAU | inhibits | gene | 0.70 |
| oxidative stress | decreases | process | 0.70 |
| AUTOPHAGY | inhibits | gene | 0.70 |
| PTEN | regulates | protein | 0.70 |
| metformin | targets | drug | 0.60 |
| CK2 | inhibits | gene | 0.60 |
| AND | activates | gene | 0.60 |
| GAIN | inhibits | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| AKT | associated_with | gene | 0.60 |
| ERK1 | activates | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| MTOR | inhibits | gene | 0.60 |
| MYC | inhibits | gene | 0.60 |
| AMBRA1 | inhibits | gene | 0.60 |
| TNF | inhibits | gene | 0.60 |
| neurogenesis | associated_with | process | 0.60 |
| NOTCH | associated_with | gene | 0.60 |
| CREB | associated_with | gene | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| PARKINSON | inhibits | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | inhibits | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| CAT | activates | gene | 0.60 |
| HMOX1 | activates | gene | 0.60 |
| LAMP1 | activates | gene | 0.60 |
| MCOLN1 | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| NFE2L2 | activates | gene | 0.60 |
| APP | phosphorylates | gene | 0.60 |
| LRP1 | activates | gene | 0.60 |
| ERK | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| NEURODEGENERATION | treats | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| TAU | interacts_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Neuron-Specific Expression of Autophagy Inhibitory Phosphata | 0.510 | neurodegeneration | What mechanisms underlie neuronal resist |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning PP2A in their description or question text
No additional research found